Volker Wacheck

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical and translational science

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda Long, Ikuo Yamamiya, Michelle Valentine, Ziv Machnes, Nanae Hangai, Bailey Anderson, Volker Wacheck, Ling Gao
A phase I drug-drug interaction study to assess the effect of futibatinib on P-gp and BCRP substrates and of P-gp inhibition on the pharmacokinetics of futibatinib. Clinical and translational science 17 (9) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, an Irreversible FGFR1-4 Inhibitor: Pooled Safety analysis of 469 patients. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, Do Youn Oh, John A Bridgewater, Masashi Shimura, Bailey Anderson, Nanae Hangai, Volker Wacheck, Lipika Goyal
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Christopher J Sweeney, Ivor J Percent, Sunil Babu, Jennifer L Cultrera, Bryan A Mehlhaff, Oscar B Goodman, David S Morris, Ian D Schnadig, Costantine Albany, Neal D Shore, Paul R Sieber, Susan C Guba, Wei Zhang, Volker Wacheck, Gregory P Donoho, Anna M Szpurka, Sophie Callies, Boris Kin Lin, Johanna C Bendell
Phase Ib/II Study of Enzalutamide with Samotolisib (LY3023414) or Placebo in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)